186 related articles for article (PubMed ID: 26198044)
1. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
[TBL] [Abstract][Full Text] [Related]
2. Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation.
Sharanek A; Burban A; Humbert L; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Drug Metab Dispos; 2017 Dec; 45(12):1292-1303. PubMed ID: 28928138
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
[TBL] [Abstract][Full Text] [Related]
5. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates.
Chatterjee S; Bijsmans IT; van Mil SW; Augustijns P; Annaert P
Toxicol In Vitro; 2014 Mar; 28(2):218-30. PubMed ID: 24211540
[TBL] [Abstract][Full Text] [Related]
7. Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.
Woolbright BL; McGill MR; Yan H; Jaeschke H
Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):160-7. PubMed ID: 26176423
[TBL] [Abstract][Full Text] [Related]
8. Identification of Bile Acids Responsible for Inhibiting the Bile Salt Export Pump, Leading to Bile Acid Accumulation and Cell Toxicity in Rat Hepatocytes.
Oizumi K; Sekine S; Fukagai M; Susukida T; Ito K
J Pharm Sci; 2017 Sep; 106(9):2412-2419. PubMed ID: 28552691
[TBL] [Abstract][Full Text] [Related]
9. A Dynamic Mathematical Model of Bile Acid Clearance in HepaRG Cells.
Kaschek D; Sharanek A; Guillouzo A; Timmer J; Weaver RJ
Toxicol Sci; 2018 Jan; 161(1):48-57. PubMed ID: 29029322
[TBL] [Abstract][Full Text] [Related]
10. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
Hu X; Bonde Y; Eggertsen G; Rudling M
J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
[TBL] [Abstract][Full Text] [Related]
11. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.
Petrov PD; Fernández-Murga L; Conde I; Martínez-Sena T; Guzmán C; Castell JV; Jover R
Arch Toxicol; 2020 Feb; 94(2):589-607. PubMed ID: 31894354
[TBL] [Abstract][Full Text] [Related]
12. From the Cover: MechanisticInsights in Cytotoxic and Cholestatic Potential of the Endothelial Receptor Antagonists Using HepaRG Cells.
Burbank MG; Sharanek A; Burban A; Mialanne H; Aerts H; Guguen-Guillouzo C; Weaver RJ; Guillouzo A
Toxicol Sci; 2017 Jun; 157(2):451-464. PubMed ID: 28369585
[TBL] [Abstract][Full Text] [Related]
13. Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model.
Ni X; Gao Y; Wu Z; Ma L; Chen C; Wang L; Lin Y; Hui L; Pan G
Sci Rep; 2016 Dec; 6():38694. PubMed ID: 27934920
[TBL] [Abstract][Full Text] [Related]
14. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
Ogimura E; Sekine S; Horie T
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.
Chatterjee S; Richert L; Augustijns P; Annaert P
Toxicol Appl Pharmacol; 2014 Jan; 274(1):124-36. PubMed ID: 24211272
[TBL] [Abstract][Full Text] [Related]
16. Iron depletion induces hepatic secretion of biliary lipids and glutathione in rats.
Prasnicka A; Cermanova J; Hroch M; Dolezelova E; Rozkydalova L; Smutny T; Carazo A; Chladek J; Lenicek M; Nachtigal P; Vitek L; Pavek P; Micuda S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Dec; 1862(12):1469-1480. PubMed ID: 28888833
[TBL] [Abstract][Full Text] [Related]
17. Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes.
Bachour-El Azzi P; Sharanek A; Burban A; Li R; Guével RL; Abdel-Razzak Z; Stieger B; Guguen-Guillouzo C; Guillouzo A
Toxicol Sci; 2015 May; 145(1):157-68. PubMed ID: 25690737
[TBL] [Abstract][Full Text] [Related]
18. Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.
Sakai Y; Okumura H; Iwao T; Watashi K; Ito K; Matsunaga T
Toxicol In Vitro; 2019 Dec; 61():104619. PubMed ID: 31394163
[TBL] [Abstract][Full Text] [Related]
19. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures.
Liu J; Lu H; Lu YF; Lei X; Cui JY; Ellis E; Strom SC; Klaassen CD
Toxicol Sci; 2014 Oct; 141(2):538-46. PubMed ID: 25055961
[TBL] [Abstract][Full Text] [Related]
20. Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells.
Sharanek A; Azzi PB; Al-Attrache H; Savary CC; Humbert L; Rainteau D; Guguen-Guillouzo C; Guillouzo A
Toxicol Sci; 2014 Sep; 141(1):244-53. PubMed ID: 24973091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
